CYBA allelic variants are associated with severity and recovery in Guillain–Barré syndrome

Abstract

AbstractBackground and AimsGuillain–Barré syndrome (GBS) is a rare, acute neuropathy characterized by ascending muscle weakness. Age, axonal GBS variants, and antecedent Campylobacter jejuni infection are associated with severe GBS, but the detailed mechanisms of nerve damage are only partly explored. Pro‐inflammatory myeloid cells express NADPH oxidases (NOX) that generate tissue‐toxic reactive oxygen species (ROS) that are implicated in neurodegenerative diseases. This study analyzed the impact of variants of the gene encoding the functional NOX subunit CYBA (p22phox) on acute severity, axonal damage, and recovery in adult GBS patients.MethodsExtracted DNA from 121 patients was genotyped for allelic variation at rs1049254 and rs4673 within CYBA using real‐time quantitative polymerase chain reaction. Serum neurofilament light chain was quantified by single molecule array. Patients were followed for severity and motor function recovery for up to 13 years.ResultsCYBA genotypes linked to reduced formation of ROS, i.e. rs1049254/G and rs4673/A, were significantly associated with unassisted ventilation, shorter time to normalization of serum neurofilament light chain and shorter time to regained motor function. Residual disability at follow‐up was confined to patients carrying CYBA alleles associated with high formation of ROS.InterpretationThese findings implicate NOX‐derived ROS in GBS pathophysiology and CYBA alleles as biomarkers of severity.